RNU7-11P

Across TCGA pan-cancer cohorts, RNU7-11P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RNU7-11P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU7-11P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU7-11P expression acts as an unfavorable survival marker, although some lineages such as STAD and LUAD show a favorable association.

STAD, LUAD, and LIHC are the cancer types where RNU7-11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.734	0.588	.003	42	view →
LUAD	DFS	Tertile	All	0.794	0.615	.015	36	view →
LIHC	OS	Tertile	II,III,IV	0.055	0.785	<.001	36	view →
UVM	OS	Tertile	III,IV	0.037	0.809	<.001	18	view →
THYM	OS	Tertile	All	0.689	0.977	.002	18	view →
BLCA	DFS	Tertile	All	0.882	0.544	.019	18	view →
COAD	OS	Tertile	III,IV	0.147	0.541	.017	18	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
UCS	OS	Tertile	All	0.363	0.609	.027	12	view →
KIRC	DFS	Tertile	IV	0.368	0.675	.005	12	view →
GBM	OS	Tertile	All	0.354	0.167	.022	9	view →
THCA	OS	Tertile	II,III,IV	0.526	0.840	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RNU7-11P–STAD (OS)

Open the STAD breakdown →